Innogest Capital

Innogest Capital is a venture capital firm with offices in Turin, Milan, Geneva and San Francisco. It concentrates on early-stage investments in technology and healthcare startups, collaborating with local and international research centers and technology transfer offices to support portfolio companies. In healthcare, the firm targets medical devices, diagnostics and digital health, with attention to therapeutic areas such as cardiovascular, neurology and oncology. In digital sectors, it backs ventures in foodtech, fintech, fashion-tech and lifestyle verticals, aiming to leverage cross-sector expertise and global networks to accelerate growth.

Hadi Abderrahim

Partner

Paolo Cellini

Digital Venture Partner

Claudio Giuliano

Co-Founder and CEO

Fernando Napolitano

Venture Partner

Diego Palano

Digital Venture Partner

Riccardo Palmisano MD

Healthcare Venture Partner

Francois Pogodalla

Digital Venture Partner

Franco Rutili

Healthcare Venture Partner

Past deals in Italy

Newronika

Series B in 2025
Newronika develops innovative neuro-modulation devices aimed at restoring brain and body functions. The company translates its deep expertise in biosignal decoding into clinical practice, enabling patients to receive targeted stimulation for improved daily activities and enhanced quality of life.

BetaGlue Technologies

Seed Round in 2022
BetaGlue Technologies SpA is a Milan-based company that specializes in the development and manufacture of medical devices designed for loco-regional radiation therapy targeting unresectable solid tumors. The company's innovative product features a proprietary beta-emitting biocompatible matrix, which facilitates the controlled administration of radionuclides directly into tumor masses. This technology not only enhances the effectiveness of cancer treatment but also plays a crucial role in preventing complications that can arise following procedures such as lung and liver biopsies. By focusing on localized therapies, BetaGlue Technologies aims to improve patient outcomes and advance the field of cancer treatment.

Everli

Series C in 2021
Everli is an online grocery shopping marketplace offering access to over 300,000 products across Italy, France, Poland, and the Czech Republic. It provides same-day delivery services, allowing customers to shop from various retailers without waiting in lines or carrying heavy items.

Everli

Venture Round in 2020
Everli is an online grocery shopping marketplace offering access to over 300,000 products across Italy, France, Poland, and the Czech Republic. It provides same-day delivery services, allowing customers to shop from various retailers without waiting in lines or carrying heavy items.

Newronika

Series A in 2019
Newronika develops innovative neuro-modulation devices aimed at restoring brain and body functions. The company translates its deep expertise in biosignal decoding into clinical practice, enabling patients to receive targeted stimulation for improved daily activities and enhanced quality of life.

Greenchic

Seed Round in 2019
Greenchic is a leading fashion logistics startup in Southern Europe, specializing in the circular economy. The company operates an online platform that allows users to swap and purchase clothing, particularly focusing on children's apparel. Users can trade in their old clothes for reward points, which can be used to acquire other pre-owned items, promoting both sustainability and affordability. Greenchic boasts a high customer retention rate and has successfully repurposed 99% of its products within six months, either through resale, upcycling, or donations. With a collection of over 240,000 items, the platform serves a highly engaged community and has received positive feedback, reflected in its 4.5-star TrustPilot rating. Operating in Italy and France, Greenchic leverages a semi-automated logistics system and a digital platform to facilitate its services, contributing to its rapid growth and positioning it as a potential leader in the European circular fashion market.

Greenchic

Seed Round in 2019
Greenchic is a leading fashion logistics startup in Southern Europe, specializing in the circular economy. The company operates an online platform that allows users to swap and purchase clothing, particularly focusing on children's apparel. Users can trade in their old clothes for reward points, which can be used to acquire other pre-owned items, promoting both sustainability and affordability. Greenchic boasts a high customer retention rate and has successfully repurposed 99% of its products within six months, either through resale, upcycling, or donations. With a collection of over 240,000 items, the platform serves a highly engaged community and has received positive feedback, reflected in its 4.5-star TrustPilot rating. Operating in Italy and France, Greenchic leverages a semi-automated logistics system and a digital platform to facilitate its services, contributing to its rapid growth and positioning it as a potential leader in the European circular fashion market.

Greenchic

Seed Round in 2018
Greenchic is a leading fashion logistics startup in Southern Europe, specializing in the circular economy. The company operates an online platform that allows users to swap and purchase clothing, particularly focusing on children's apparel. Users can trade in their old clothes for reward points, which can be used to acquire other pre-owned items, promoting both sustainability and affordability. Greenchic boasts a high customer retention rate and has successfully repurposed 99% of its products within six months, either through resale, upcycling, or donations. With a collection of over 240,000 items, the platform serves a highly engaged community and has received positive feedback, reflected in its 4.5-star TrustPilot rating. Operating in Italy and France, Greenchic leverages a semi-automated logistics system and a digital platform to facilitate its services, contributing to its rapid growth and positioning it as a potential leader in the European circular fashion market.

Greenchic

Seed Round in 2018
Greenchic is a leading fashion logistics startup in Southern Europe, specializing in the circular economy. The company operates an online platform that allows users to swap and purchase clothing, particularly focusing on children's apparel. Users can trade in their old clothes for reward points, which can be used to acquire other pre-owned items, promoting both sustainability and affordability. Greenchic boasts a high customer retention rate and has successfully repurposed 99% of its products within six months, either through resale, upcycling, or donations. With a collection of over 240,000 items, the platform serves a highly engaged community and has received positive feedback, reflected in its 4.5-star TrustPilot rating. Operating in Italy and France, Greenchic leverages a semi-automated logistics system and a digital platform to facilitate its services, contributing to its rapid growth and positioning it as a potential leader in the European circular fashion market.

Everli

Series B in 2018
Everli is an online grocery shopping marketplace offering access to over 300,000 products across Italy, France, Poland, and the Czech Republic. It provides same-day delivery services, allowing customers to shop from various retailers without waiting in lines or carrying heavy items.

EryDel

Series B in 2018
EryDel, based in Urbino, has developed a patented technology for drug delivery utilizing erythrocytes, or red blood cells. This innovative approach enables the efficient loading of red blood cells with various therapeutic agents, including drugs, proteins, and nanoparticles, which can be gradually released into the patient's body. The technology enhances treatment efficacy while minimizing side effects, particularly for chronic conditions that typically require daily medication. EryDel's solution has undergone testing in patients suffering from Inflammatory Bowel Diseases such as ulcerative colitis and Crohn's disease. Additionally, the company provides comprehensive support for the drug delivery process through its specialized device, the "Red Cell Loader," and associated disposable kits. This system aims to streamline blood processing at the point of care, enabling healthcare professionals to deliver therapies for a range of conditions efficiently.

Greenchic

Seed Round in 2018
Greenchic is a leading fashion logistics startup in Southern Europe, specializing in the circular economy. The company operates an online platform that allows users to swap and purchase clothing, particularly focusing on children's apparel. Users can trade in their old clothes for reward points, which can be used to acquire other pre-owned items, promoting both sustainability and affordability. Greenchic boasts a high customer retention rate and has successfully repurposed 99% of its products within six months, either through resale, upcycling, or donations. With a collection of over 240,000 items, the platform serves a highly engaged community and has received positive feedback, reflected in its 4.5-star TrustPilot rating. Operating in Italy and France, Greenchic leverages a semi-automated logistics system and a digital platform to facilitate its services, contributing to its rapid growth and positioning it as a potential leader in the European circular fashion market.

Digital Magics

Post in 2016
Digital Magics S.p.A., founded in 2003 and based in Milan, Italy, operates as a business incubator that focuses on supporting startups in the digital and technology sectors. The company offers a range of services aimed at enhancing and accelerating business growth, from initial concept development to preparation for public offerings. In collaboration with Talent Garden and Tamburi Investment Partners, Digital Magics has established a significant national innovation hub dedicated to promoting MADE IN ITALY DIGITAL TECHNOLOGIES. Their Open Innovation services create a collaborative environment for established companies and emerging digital startups. Digital Magics provides its incubation and acceleration services across Talent Garden coworking campuses throughout Italy. Additionally, the firm has built a portfolio of over 99 investments in startups, scale-ups, and digital spin-offs, demonstrating its commitment to fostering high-growth potential enterprises.

Everli

Series A in 2016
Everli is an online grocery shopping marketplace offering access to over 300,000 products across Italy, France, Poland, and the Czech Republic. It provides same-day delivery services, allowing customers to shop from various retailers without waiting in lines or carrying heavy items.

Newronika

Venture Round in 2016
Newronika develops innovative neuro-modulation devices aimed at restoring brain and body functions. The company translates its deep expertise in biosignal decoding into clinical practice, enabling patients to receive targeted stimulation for improved daily activities and enhanced quality of life.

Greenchic

Seed Round in 2016
Greenchic is a leading fashion logistics startup in Southern Europe, specializing in the circular economy. The company operates an online platform that allows users to swap and purchase clothing, particularly focusing on children's apparel. Users can trade in their old clothes for reward points, which can be used to acquire other pre-owned items, promoting both sustainability and affordability. Greenchic boasts a high customer retention rate and has successfully repurposed 99% of its products within six months, either through resale, upcycling, or donations. With a collection of over 240,000 items, the platform serves a highly engaged community and has received positive feedback, reflected in its 4.5-star TrustPilot rating. Operating in Italy and France, Greenchic leverages a semi-automated logistics system and a digital platform to facilitate its services, contributing to its rapid growth and positioning it as a potential leader in the European circular fashion market.

Prestiamoci

Venture Round in 2015
Prestiamoci S.p.A. is an innovative online peer-to-peer lending platform based in Milan, Italy, founded in 2007. It specializes in connecting individuals seeking loans with investors looking to lend money, facilitating a direct borrowing and lending relationship. This platform allows users to obtain loans with transparent installment terms, enabling them to finance personal projects, manage expenses, and support professional growth. By fostering a community of loans, Prestiamoci empowers individuals to regain the traditional role of a bank, creating a safe environment for both borrowers and lenders to achieve their financial goals.

Angiodroid

Venture Round in 2015
Angiodroid srl is a medical technology company based in San Lazzaro di Savena, Italy, specializing in hemodynamics, vascular surgery, and interventional radiology. The company develops an automatic injection system specifically for carbon dioxide angiography, which serves as a contrast medium in peripheral interventional angiography. Angiodroid's offerings include a carbon dioxide injector and a single-use kit that comprises French catheters and a custom connection line. By combining clinical and engineering expertise with insights into patient needs, Angiodroid aims to enhance treatment options for patients, particularly those suffering from diabetic disease and renal failure, while minimizing the risk of complications associated with conventional methods.

New Vision

Venture Round in 2014
New Vision, a Padua, Italy-based startup that develops a platform to manage content. It features a collaboration environment to save, modify and share files and and communicate in real time with teammates, video and media management tools to distribute content on the web, on social networks, apps, in store communication solutions and interactive live platforms to organize live events in streaming, public or reserved to a few users.

Formabilio

Venture Round in 2014
Formabilio is an online platform that connects Italian craftsmanship with innovative ideas from emerging and established designers. Founded by Andrea Carbone and Maria Grazia Andali, the company aims to promote participatory design and elevate the Made in Italy brand on a global scale. Formabilio hosts design contests where designers can submit furniture and furnishing concepts, which are then voted on by the community. The most popular designs are produced by small Italian manufacturers and sold through the Formabilio website. The company operates on a crowdsourcing model, sharing the outcomes of its projects with all contributors, from designers to manufacturers. With a community of 65,000 registered users, including 1,100 designers and a total of 1,500 submitted projects, Formabilio emphasizes collaboration and ethical business practices in its operations.

Thron

Venture Round in 2014
THRON S.p.A. is a software company based in Piazzola sul Brenta, Italy, specializing in a content strategy platform designed for marketers. The company provides a digital asset management (DAM) solution that enables brands to centralize, manage, and deliver content across multiple channels. THRON's platform integrates various content-related processes, allowing organizations to organize digital assets such as images, videos, and documents effectively. With features that include omnichannel workflows, artificial intelligence for personalized communication, and strategic insights into customer interests, THRON empowers clients to enhance user engagement and retention. Founded in 2000, the company aims to give its clients a comprehensive view of their customers and facilitate real-time interactions, ultimately helping brands to mobilize and connect effectively on a global scale.

Withfounders

Venture Round in 2014
WithFounders is a startup accelerator based in Milan, Italy, established in 2013 by Michele Casucci, Marco De Palma, and Julius Valiante. The company focuses on supporting entrepreneurs in building digital and consumer-oriented businesses by providing capital and coaching. WithFounders specializes in initiatives that enhance traditional businesses through technology, particularly in the digital media sector. Its mission is to foster innovation and growth among startups by leveraging its expertise and resources to guide them through the challenges of early-stage development.

EryDel

Series B in 2013
EryDel, based in Urbino, has developed a patented technology for drug delivery utilizing erythrocytes, or red blood cells. This innovative approach enables the efficient loading of red blood cells with various therapeutic agents, including drugs, proteins, and nanoparticles, which can be gradually released into the patient's body. The technology enhances treatment efficacy while minimizing side effects, particularly for chronic conditions that typically require daily medication. EryDel's solution has undergone testing in patients suffering from Inflammatory Bowel Diseases such as ulcerative colitis and Crohn's disease. Additionally, the company provides comprehensive support for the drug delivery process through its specialized device, the "Red Cell Loader," and associated disposable kits. This system aims to streamline blood processing at the point of care, enabling healthcare professionals to deliver therapies for a range of conditions efficiently.

BeeTV

Series C in 2011
BeeTV is a social TV service that is a real-time, cross-platform hub for all consumers' activity around TV. BeeTV's goal is to revolutionize the TV experience by helping consumers improve how they communicate about, discover, share and consume TV content by making a traditionally social experience social in the digital world as well. Founded by leading media and technology veterans, BeeTV has deployed with major cable operators in Europe and is launching its consumer Internet Social TV service in the United States in May 2011. BeeTV is based in Tel Aviv, Israel and has business offices in Milan, Italy and San Francisco, California. The company is backed by Innogest, the leading Italian venture capital firm.

Menarini Silicon Biosystems

Venture Round in 2010
Menarini Silicon Biosystems develops lab-on-a-chip technologies for miniaturized cell-biology testing. It offers SmartSlide, a disposable lab-on-a-chip for sample enrichment and label-free cell separation, and DEPArray, a cell microarray that enables individual cell manipulation and detection. The company provides tools for cell sorting and single-cell analysis to study cellular interactions and heterogeneity, with applications including circulating tumor cell isolation, liquid biopsy, rare cell isolation, and molecular analysis. By enabling high-resolution analysis of single cells, the firm addresses questions in disease biology and supports research into tumor heterogeneity, forensics, and other fields. Headquartered in Bologna, Italy, the company focuses on understanding the biological complexity of disease by advancing single-cell technologies that allow researchers to resolve cellular diversity and interactions at the individual cell level.

BeeTV

Series B in 2009
BeeTV is a social TV service that is a real-time, cross-platform hub for all consumers' activity around TV. BeeTV's goal is to revolutionize the TV experience by helping consumers improve how they communicate about, discover, share and consume TV content by making a traditionally social experience social in the digital world as well. Founded by leading media and technology veterans, BeeTV has deployed with major cable operators in Europe and is launching its consumer Internet Social TV service in the United States in May 2011. BeeTV is based in Tel Aviv, Israel and has business offices in Milan, Italy and San Francisco, California. The company is backed by Innogest, the leading Italian venture capital firm.

EryDel

Series A in 2008
EryDel, based in Urbino, has developed a patented technology for drug delivery utilizing erythrocytes, or red blood cells. This innovative approach enables the efficient loading of red blood cells with various therapeutic agents, including drugs, proteins, and nanoparticles, which can be gradually released into the patient's body. The technology enhances treatment efficacy while minimizing side effects, particularly for chronic conditions that typically require daily medication. EryDel's solution has undergone testing in patients suffering from Inflammatory Bowel Diseases such as ulcerative colitis and Crohn's disease. Additionally, the company provides comprehensive support for the drug delivery process through its specialized device, the "Red Cell Loader," and associated disposable kits. This system aims to streamline blood processing at the point of care, enabling healthcare professionals to deliver therapies for a range of conditions efficiently.

TheBlogTV

Series A in 2007
TheBlogTV is a European social media company with operations in Italy, France, Spain, and England. Established in 2006, it specializes in creating, activating, and managing online communities for top business clients. The company's core services include developing projects on web and mobile platforms to generate measurable value, producing content, community management, and social media marketing. Additionally, TheBlogTV produces social video content for TV and websites through traditional methods and user-generated content via UserFarm and video crowdsourcing. Notable clients include Microsoft, Juventus FC, Nestlé Purina, and various media outlets like Rai4 and Sky.

Menarini Silicon Biosystems

Series B in 2007
Menarini Silicon Biosystems develops lab-on-a-chip technologies for miniaturized cell-biology testing. It offers SmartSlide, a disposable lab-on-a-chip for sample enrichment and label-free cell separation, and DEPArray, a cell microarray that enables individual cell manipulation and detection. The company provides tools for cell sorting and single-cell analysis to study cellular interactions and heterogeneity, with applications including circulating tumor cell isolation, liquid biopsy, rare cell isolation, and molecular analysis. By enabling high-resolution analysis of single cells, the firm addresses questions in disease biology and supports research into tumor heterogeneity, forensics, and other fields. Headquartered in Bologna, Italy, the company focuses on understanding the biological complexity of disease by advancing single-cell technologies that allow researchers to resolve cellular diversity and interactions at the individual cell level.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.